{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T07:50:04Z","timestamp":1764575404458,"version":"3.46.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009663","name":"University Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.seizure.2024.10.001","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T09:57:54Z","timestamp":1729072674000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neurological care and outcomes in a cohort of Canadian pregnant patients with epilepsy"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-9192","authenticated-orcid":false,"given":"Julien","family":"H\u00e9bert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-1332","authenticated-orcid":false,"given":"Sharon","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajur","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina S.-W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-8916","authenticated-orcid":false,"given":"John W.","family":"Snelgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5785-9524","authenticated-orcid":false,"given":"Esther","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2024.10.001_bib0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0002","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"unstructured":"Ng R., Maxwell C.J., Yates E.A., Nylen K., Antflick J., Jett\u00e9 N., et al. Brain disorders in Ontario: prevalence, incidence and costs from health administrative data. 2015.","key":"10.1016\/j.seizure.2024.10.001_bib0003"},{"unstructured":"Canadian Chronic Disease Surveillance System (CCDSS) n.d. https:\/\/health-infobase.canada.ca\/ccdss\/data-tool\/(accessed December 18, 2020).","key":"10.1016\/j.seizure.2024.10.001_bib0004"},{"key":"10.1016\/j.seizure.2024.10.001_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ncl.2012.05.001","article-title":"Physiologic Adaptations to Pregnancy","volume":"30","author":"Chang","year":"2012","journal-title":"Neurol Clin"},{"key":"10.1016\/j.seizure.2024.10.001_bib0006","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/0024-3205(81)90541-5","article-title":"A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations","volume":"29","author":"Nau","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.seizure.2024.10.001_bib0007","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.seizure.2024.10.001_bib0008","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2024.10.001_bib0009","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2024.10.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008001","article-title":"Declining malformation rates with changed antiepileptic drug prescribing: an observational study","volume":"93","author":"Tomson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0011","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0012","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2024.10.001_bib0013","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2024.10.001_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/jpme.1979.7.1.3","article-title":"Fetal heart rate during a maternal grand mal epileptic seizure","volume":"7","author":"Teramo","year":"1979","journal-title":"J Perinat Med"},{"key":"10.1016\/j.seizure.2024.10.001_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4065\/78.4.497","article-title":"Epilepsy and women's health: family planning, bone health, menopause, and menstrual-related seizures","volume":"78","author":"Liporace","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.seizure.2024.10.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0017","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/cjn.2022.3","article-title":"The North American Antiepileptic Drug Pregnancy Registry: a Canadian Subgroup Analysis","volume":"50","author":"H\u00e9bert","year":"2023","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"10.1016\/j.seizure.2024.10.001_bib0018","first-page":"1","article-title":"Obstetrical outcomes of patients with epilepsy in a Canadian tertiary care center (2014\u20132020)","author":"H\u00e9bert","year":"2023","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"unstructured":"Statistics Canada. Citizenship by visible minority and immigrant status and period of immigration: canada, provinces and territories and federal electoral districts (2013 Representation Order) 2022. https:\/\/doi.org\/10.25318\/9810030301-ENG.","key":"10.1016\/j.seizure.2024.10.001_bib0019"},{"key":"10.1016\/j.seizure.2024.10.001_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.0000000000002249","article-title":"Disparities in surgery among patients with intractable epilepsy in a universal health system","volume":"86","author":"Burneo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhealeco.2015.08.004","article-title":"Mandatory universal drug plan, access to health care and health: evidence from Canada","volume":"44","author":"Wang","year":"2015","journal-title":"J Health Econ"},{"key":"10.1016\/j.seizure.2024.10.001_bib0022","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1017\/cjn.2021.190","article-title":"Epilepsy and pregnancy: an audit of specialized care","volume":"49","author":"Li","year":"2022","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"unstructured":"Toronto, C. [Census subdivision], Ontario and Ontario [Province] (table) 2017.","key":"10.1016\/j.seizure.2024.10.001_bib0023"},{"key":"10.1016\/j.seizure.2024.10.001_bib0024","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"unstructured":"UHN at a Glance 2024. https:\/\/www.uhn.ca\/corporate\/AboutUHN\/Pages\/uhn_at_a_glance.aspx (accessed September 3, 2024).","key":"10.1016\/j.seizure.2024.10.001_bib0025"},{"unstructured":"Ontario Epilepsy Guidelines: DECs and RESC 2024. https:\/\/ontarioepilepsyguidelines.ca\/decs-and-rescs\/.","key":"10.1016\/j.seizure.2024.10.001_bib0026"},{"unstructured":"Statistics Canada. Focus on Geography Series, 2021 Census of Population: toronto, Census metropolitan area 2022. https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/as-sa\/fogs-spg\/page.cfm?lang=E&topic=1&dguid=2021S0503535 (accessed September 10, 2024).","key":"10.1016\/j.seizure.2024.10.001_bib0027"},{"unstructured":"Statistics Canada. Population estimates, quarterly (Statistics Canada Table: 17-10-0009-01) 2024. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000901 (accessed September 10, 2024).","key":"10.1016\/j.seizure.2024.10.001_bib0028"},{"key":"10.1016\/j.seizure.2024.10.001_bib0029","first-page":"75","article-title":"The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies","volume":"75","author":"Nicolson","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2024.10.001_bib0030","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMoa2008663","article-title":"Changes in seizure frequency and antiepileptic therapy during pregnancy","volume":"383","author":"Pennell","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2024.10.001_bib0031","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.10.001_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yebeh.2017.10.017","article-title":"Predicting epileptic seizure control during pregnancy","volume":"78","author":"Vajda","year":"2018","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.seizure.2024.10.001_bib0033","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","article-title":"Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy","volume":"29","author":"Reisinger","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2024.10.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2012.03439.x","article-title":"Predictors of seizures during pregnancy in women with epilepsy","volume":"53","author":"Thomas","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.10.001_bib0035","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/epi.18022","article-title":"Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: a population-based study from Nordic universal health care systems","volume":"65","author":"Leinonen","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.10.001_bib0036","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/epi.12302","article-title":"Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry","volume":"54","author":"Battino","year":"2013","journal-title":"Epilepsia"},{"year":"2016","author":"Wickham","series-title":"ggplot2: elegant graphics for data analysis","key":"10.1016\/j.seizure.2024.10.001_bib0037"},{"key":"10.1016\/j.seizure.2024.10.001_bib0038","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2021.06.014","article-title":"Female preponderance in genetic generalized epilepsies","volume":"91","author":"Videira","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.10.001_bib0039","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pds.5035","article-title":"Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: a study in the five Nordic countries, United States, and Australia","volume":"29","author":"Cohen","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.seizure.2024.10.001_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.0000000000001304","article-title":"Antiepileptic drug use by pregnant women enrolled in Florida Medicaid","volume":"84","author":"Wen","year":"2015","journal-title":"Neurology"},{"year":"2015","series-title":"Provincial guidelines for the management of epilepsy in adults and children: epilepsy implementation task force","key":"10.1016\/j.seizure.2024.10.001_bib0041"},{"key":"10.1016\/j.seizure.2024.10.001_bib0042","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2024.10.001_bib0043","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/epi.16882","article-title":"Valproate usage in pregnancy: an audit from the Kerala Registry of Epilepsy and Pregnancy","volume":"62","author":"Seshachala","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.10.001_bib0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2022.03.020","article-title":"National compliance with UK wide guidelines for usage of valproate in women of childbearing potential","volume":"98","author":"Eriksson","year":"2022","journal-title":"Seizure"},{"unstructured":"Canadian Institute for Health Information.: cOVID-19\u2019s impact on physician services. 2021. https:\/\/www.cihi.ca\/en\/covid-19-resources\/impact-of-covid-19-on-canadas-health-care-systems\/hospital-services (accessed July 9, 2024).","key":"10.1016\/j.seizure.2024.10.001_bib0045"},{"key":"10.1016\/j.seizure.2024.10.001_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1135962","article-title":"Prescription trends of antiseizure medications before and during the COVID-19 pandemic","volume":"14","author":"Lavu","year":"2023","journal-title":"Front Neurol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112400284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112400284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T07:46:30Z","timestamp":1764575190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913112400284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S105913112400284X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.10.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological care and outcomes in a cohort of Canadian pregnant patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}